HAEMONETICS CORP 4
4 · HAEMONETICS CORP · Filed Jul 26, 2013
Insider Transaction Report
Form 4
BEST LAWRENCE C
Director
Transactions
- Award
Non-Qualified Stock Option (right to buy)
2013-07-24+6,573→ 6,573 totalExercise: $45.45From: 2014-07-24Exp: 2023-07-24→ Common Stock (6,573 underlying) - Award
Common Stock
2013-07-24+1,649→ 10,001 total
Holdings
- 8,580
Non-Qualified Stock Option (right to buy)
Exercise: $27.24From: 2011-07-29Exp: 2017-07-29→ Common Stock (8,580 underlying) - 11,758
Non-Qualified Stock Option (right to buy)
Exercise: $29.72From: 2010-07-30Exp: 2016-07-30→ Common Stock (11,758 underlying) - 11,328
Non-Qualified Stock Option (right to buy)
Exercise: $29.23From: 2009-07-31Exp: 2018-07-31→ Common Stock (11,328 underlying) - 8,196
Non-Qualified Stock Option (right to buy)
Exercise: $36.37From: 2013-07-27Exp: 2019-07-27→ Common Stock (8,196 underlying) - 9,184
Non-Qualified Stock Option (right to buy)
Exercise: $24.96From: 2008-08-01Exp: 2014-08-01→ Common Stock (9,184 underlying) - 7,118
Non-Qualified Stock Option (right to buy)
Exercise: $34.41From: 2012-07-21Exp: 2018-07-21→ Common Stock (7,118 underlying)
Footnotes (3)
- [F1]Restricted Stock Unit Grant which vest 100% on the first anniversary of the grant date. Grant was made under 2005 Long Term Incentive Compensation Plan.
- [F2]Total includes Restricted Stock Awards and/or Restricted Stock Units that are subject to restrictions until vesting requirements are met. Grant was made under 2005 Long Term Incentive Compensation Plan.
- [F3]Grant to reporting person of right to buy shares of common stock exercisable 100 percent on the first anniversary of the date of grant.